The molecular mechanisms behind the entry of the primordial follicle into the growing follicle pool remain poorly understood. To investigate this process further, a microarray-based comparison was undertaken between 2-day postpartum mouse ovaries consisting of primordial follicles/ naked oocytes only and those with both primordial follicles and newly activated follicles (7-day postpartum). Gene candidates identified included the chemoattractive cytokine stromal derived factor-1 (SDF1) and its receptor CXCR4. SDF1 and CXCR4 have been implicated in a variety of physiological processes including the migration of embryonic germ cells to the gonads. SDF1-α expression increased with the developmental stage of the follicle. Embryonic expression was found to be dichotomous post-germ cell migration, with low expression in the female. Immunohistochemical studies nonetheless indicate that the autocrine pattern of expression ligand and receptor begins during embryonic life. Addition of recombinant SDF1-α to neonatal mouse ovaries in vitro resulted in significantly higher follicle densities than for control ovaries. TUNEL analysis indicated no detectable difference in populations of apoptotic cells of treated or control ovaries. Treated ovaries also contained a significantly lower percentage of activated follicles as determined by measurement of oocyte diameter and morphological analysis. Treatment of cultured ovaries with an inhibitor of SDF1-α, AMD3100, ablated the effect of SDF1-α. By retaining follicles in an unactivated state, SDF1/ CXCR4 signaling may play an important role in maintaining the size and longevity of the primordial follicle pool.
Introduction
The molecular mechanisms controlling the entry of the primordial follicle into the growing follicle pool remain obscure, yet a more complete understanding of the process may aid in overcoming certain forms of female infertility. A number of paracrine factors have been implicated in the balance between activation and suppression of primordial follicle growth. Leukemia inhibitory factor (LIF) (Nilsson et al., 2002) , basic fibroblast growth factor (bFGF) (Nilsson et al., 2001) , stem cell factor (SCF) (Parrott and Skinner, 1999) , and bone morphogenic protein-4 (Nilsson and Skinner, 2003) and -7 (Lee et al., 2004) are positive regulators of the system, while anti-Müllerian hormone (AMH) has been shown to inhibit the primordial to primary transition (Durlinger et al., 1999 (Durlinger et al., , 2002a .
Chemokines are a family of greater than 50 structurally related, small molecular weight chemoattractive cytokines. SDF1 (also called CXCL12) is a chemokine that was originally identified as a molecule expressed by a bonemarrow-derived stromal cell line that acted as a stimulator of pre-B-cell growth (Nagasawa et al., 1994) . SDF1 is generally thought to have a single receptor-the seven transmembrane G-protein-coupled receptor CXCR4, which is also a coreceptor for the X4 strains of the human immunodeficiency virus (Feng et al., 1996) . Recent evidence however suggests SDF1 may bind and signal through other receptors including orphan receptor RDC1 and syndecan-4 (Balabanian et al., 2005; Charnaux et al., 2005) . Constitutively expressed in a variety of tissues, the pair are also widely expressed by malignant cells (Balkwill, 2004; Pablos et al., 1999) . Knockout models have emphasized the importance of this signaling couple in the development of B lymphocytes, GI tract blood vessel development, heart septum formation, neuron localization (Ma et al., 1998; Tachibana et al., 1998) . Deletion of either the CXCR4 or SDF1 genes results in embryonic lethality (Nagasawa et al., 1996; Tachibana et al., 1998; Zou et al., 1998) . A role for the signaling axis has been established in the migration of primordial germ cells from the hindgut to the gonads, with SDF −/− mutant mice displaying delayed migration and decreased numbers of primordial germ cells in the gonads (Ara et al., 2003; Molyneaux et al., 2003; Stebler et al., 2004) . SDF1 exists in three transcript variant forms, SDF1-α, -β, and -γ that arise by alternate splicing from a single gene and correspond to proteins of 89, 93, and 119 amino acids respectively (Gleichmann et al., 2000; Jiang et al., 1994) . SDF-β differs from SDF-α by a four amino acid extension at the carboxy terminus. Mouse SDF-α and -β are greater than 92% identical to their human homologs (Shirozu et al., 1995) .
The ovarian processes of follicular atresia, ovulation, corpus luteum formation and luteal regression are characteristic of an inflammatory response, with the role of leukocytes and their secretory products central to these events (Bukulmez and Arici, 2000; Townson and Liptak, 2003a) . As such, a number of chemokines have been identified within the mammalian mouse adult ovary including MCP-1 and RANTES and their receptors (Zhou et al., 2004) . The identification of SDF1 and CXCR4 in the neonatal ovary as a result of an ovarian transcriptome project was of particular interest to us considering the neonatal ovary lacks mature follicles. We therefore undertook expression and functional studies to determine what role this chemokine and receptor play in the early stages female germ cell development.
Materials and methods
Use of animals for this study was approved by the University of Newcastle and University of Queensland Animal Care and Ethics Committees. All chemicals and reagents were obtained from Sigma (Sigma, USA) or Research Organics (Research Organics Inc., USA) unless otherwise stated. Cell culture media and supplements were obtained from Sigma and Gibco (Gibco™ Invitrogen Corporation, Australia).
Tissue collection and RNA extraction
Embryonic, neonatal, or adult Swiss outbred mice or Quackenbush mice were euthanized via decapitation, cervical dislocation, or CO 2 asphyxiation and organs removed and snap frozen in liquid nitrogen. RNA was extracted from tissues using Trizol reagent (Invitrogen, Australia), according to the manufacturer's directions.
Microarray analysis
RNA to be used for microarray analysis was amplified from 500 ng of total RNA using a modified van Gelder/Eberwine protocol (Gelder et al., 1990) . First strand synthesis was performed using Superscript III reagents (Invitrogen, Australia), according to the manufacturer's directions. Second strand synthesis was performed using Advantage 2 Taq Polymerase (BD Biosciences Clontech, USA), according to directions, with the addition of RNase H. T7 RNA amplification was performed using the MegaScript kit (Ambion, Inc., USA). Following precipitation, 500 ng of RNA was subjected to a second round of amplification using random hexamer priming. Amino-allyl labeled cDNA was prepared from 6 μg of amplified RNA and labeled with Cy3 or Cy5 dyes using the CyScribe Post-labeling Kit (Amersham, Sweden) according to directions. Equivalent amounts of Cy3 and Cy5 were hybridized overnight in a humidified chamber at 42°C to slides spotted with the NIA mouse 15 K cDNA set (AGRF, Australia). Slides were washed once with 55°C 1× SSC, 0.2% SDS, twice in 0.1× SSC, 0.2% SDS, twice in 0.1× SSC and once in water prior to rapid drying and scanning on an Axon Scanner (Molecular Devices Corporation, USA). Data analysis was performed using GeneSpring Software using Lowess normalization, using background subtraction with buffer spots as negative controls.
CodeLink microarrays
Gene expression analysis was performed utilizing CodeLink™ Mouse Whole Genome Array slides (GE Healthcare, UK) according to the manufacturer's instructions. Briefly, cDNA was generated from approximately 2 μg of total RNA from neonatal mouse ovaries. An in vitro transcription was performed, incorporating biotinylated UTP in the resulting amplified RNA (aRNA). Ten micrograms of aRNA was hybridized with the Mouse Whole Genome Slide and detection of hybridization carried out by probing with Cy5-streptavidin. Slides were scanned in an Axon scanner and data analyzed with proprietary CodeLink™ Expression Analysis Software (GE Healthcare, UK).
Affymetrix microarray analysis
Quackenbush mouse embryos were collected at the appropriate day and sexed as previously described (Wilson et al., 2005) . 5-10 sexed gonad pairs were pooled into their appropriate age/sex-specific group in triplicate. Total RNA was extracted using Qiagen's RNeasy® Micro Kit as per manufacturer's instructions. Samples showing excessive degradation based on 260:280 ratio (outside the 1.8-2.1 range) or the presence of a brighter 28S band than the 18S band following agarose gel electrophoresis were disregarded. Remaining pooled samples containing >300 ng total RNA were used to make biotin labeled aRNA using Ambion's MessageAmp II aRNA Amplification kit as per manufactures instructions. aRNA was fragmented using fragmentation buffer (final concentration of 1×) at 94°C for 35 min. 10 μg of aRNA samples was prepared and hybridized on Affymetrix mouse 430v2 chips as per manufacturer's instructions for the 49 format (Standard)/64 format arrays. Chips were hybridized for 16 h at 45°C at 60 rpm, before being washed and stained on a Fluidics Station 450 using protocol EukGE-WS2v5. The chips were then scanned with an Agilent GeneArray Scanner 3000 and preliminary analyzed using Affymetrix Genechip Operating Software v1.2 (GCOS) was carried out to confirm Chip integrity, RNA integrity and control signals. Chips were scaled to a target signal of 150 in GCOS, and raw data in GeneSpring were normalized to the median signal using GC-RMA normalization using a RAW signal cut-off of 0.01. CEL files from GCOS were also analyzed in DNA-Chip Analyzer software (DChip). CEL files were entered into DChip and normalized against the baseline array showing the median overall intensity. Normalized data were then exported into Microsoft Excel and plotted.
RT-PCR transcript analysis
Two micrograms of total RNA from mouse tissues was reverse transcribed with oligo(dT) 15 primer (Promega, USA) or random hexamers and M-MLV Reverse Transcriptase RNase H − (Promega). PCR was performed using the forward primer 5′-gctgccgcactttcactctc-3′ and reverse primers specific for the 3 SDF1 splice variants: SDF1-α alpha: 5′-CCACCACTGCCCTTGCATCT-3′, SDF1-β 5′-ACATAGTGGCCTTGGCCTGT-3′ and SDF1-γ , 5′-CTTTAGCA-GACAGAGCAGGGC-3′ with expected product sizes of 440 bp, 612 and 663 bp, respectively. The PCR reaction conditions were as follows: 1 cycle of 94°C for 5 min; 35 cycles of 95°C for 45 s, 57°C for 45 s, 72°C 45 s; 1 cycle of 72°C for 10 min. The integrity of each cDNA sample was checked by β-actin PCR using forward primer 5′-TGGATGATGATATCGCCGCG-3′ and reverse 5′-CTAGAAGCATTTGCGGTGGACGATGGAGGGGCC-3′ using an annealing temperature of 60°C and extension time of 2 min. PCR products cloned into the pGEM-T Easy vector (Promega, USA) prior to sequencing (AGRF, Australia).
Real-time PCR
Total RNA was treated with DNAse (Promega) prior to reverse transcription as previously described. PCR was performed on an Opticon real-time thermocycler (Bio-Rad Laboratories, Australia) using SyBr Green Mastermix according to the manufacturers directions, using an annealing temperature of 64°C for 40 cycles. Primers used were: SDF1-α/β forward 5′-CGCTCTGCAT-CAGTGACGGTA-3′ and reverse 5′-GTTCTTCAGCCGTGCAACAATC-3′; CXCR4 QuantiTect Primer Assay Primers QT00249305 (Qiagen), Cyclophilin: forward 5′-CGTCTCCTTCGAGCTGTTT-3′ and reverse 5′-ACCCTGGCA-CATGAATCCT-3′, 18S rRNA forward 5′-CGGCTACCACATCCAAGGAA-3′ and reverse 5′-GCTGGAATTACCGCGGCT-3′ with an annealing temperature of 64°C. Primer efficiencies of SDF1 and CXCR4 versus cyclophilin were confirmed as being similar by correlation analysis of cycle threshold (Ct) values of 10-fold dilutions of ovary cDNA. For expression analysis, data from 3 replicates were analyzed using the 2 −ΔΔC T method.
In situ hybridization
Probes were prepared from PCR products amplified with SDF1 RT primers and CXCR4 primers-forward: 5′-CTCCAACAAGGAACCCTGCT-3′ and reverse: 5′-TGGCATCAACTGCCCAGAAG-3′. Inserts were cloned into pGEM-T Easy and probes transcribed using Sp6 or T7 polymerase with digoxygenenin-labeled ribonucleotides incorporated (Roche Molecular Biochemicals, Germany). Sections were pre-treated and hybridized according to established protocols (Yang et al., 1999) . Overnight incubations were performed at 45°C, with post-hybridization washed at 55°C (SDF1) or 50°C (CXCR4). Probe detection was performed using an alkaline phosphatase-conjugated anti-DIG antibody (DAKO, Denmark) (1:500) with NBT/BCIP substrate (Roche Molecular Biochemicals, Germany). Sections were counterstained with hematoxylin prior to mounting and photography.
Immunohistochemistry
IHC was carried out on paraformaldehyde-fixed, paraffin-embedded sections using SDF1-α and CXCR4 polyclonal antibodies at a dilution of 1:100(Abcam Ltd., UK). Sections were incubated at 4°C overnight prior to visualization using the Envision Plus System (DakoCytomation, Denmark) secondary antibody and 3,3′-diaminobenzidine staining, followed by hematoxylin counterstaining. For dual immunostaining, primary antibodies were incubated simultaneously followed by incubation with anti-rabbit rhodamineconjugated secondary antibody (1:200) then an anti-goat FITC-conjugated antibody (1:80) (Chemicon, USA). Slides were mounted with SlowFade® Light Antifade reagent (Molecular Probes, USA) prior to imaging with a LSM510 laser-scanning microscope (Carl Zeiss Pty) equipped with Argon and Helium/ Neon lasers at excitation wavelengths of 488 and 543 nm and emission spectra of 500-530 nm (FITC) and greater than 560 nm (Rhodamine).
Ovarian explant culture
Ovaries were excised, their bursae removed and placed on membrane inserts (Millipore Billerica, MA, USA) placed above 24-well tissue culture plate wells with culture media containing DMEM/F12, 5% FCS, 0.1% BSA, ascorbic acid (50 μg/ml), insulin-transferrin-selenium, 2.5 mM glutamine and penicillin/ streptomycin (Gibco). Media were supplemented with bFGF (40 ng/ml), LIF (50 ng/ml), SCF (25 ng/ml) with or without SDF1-α (10 ng/ml-250 ng/ml). Ovaries were cultured for 5 days, with media changes every other day. Ovaries were treated with recombinant mouse SDF1-α, AMD3100 or PBS alone with fresh ligand added with each media change (R&D Systems, USA). Following culture ovaries were fixed in 4% paraformaldehyde, paraffin-embedded and 5-μm sections counterstained with hematoxylin and eosin. Ovaries were sectioned in entirety and where possible sections mid-way through the block selected for analysis. Two or more ovaries per treatment were viewed, with an average count value taken on ovaries sections separated by 15 μm. Measurements for ovary density and diameter were performed using an ocular micrometer. Effects of SDF-α on follicle density or oocyte diameter were analyzed by one-way ANOVA followed by a Tukey's HSD (honestly significant difference) test or Student's t test, with probabilities of 0.02 or 0.05 or less considered significant.
TUNEL analysis
Paraformaldehyde-fixed sections were deparaffinized, re-hydrated and treated with 2× SSC at 80°C for 20 min, dH 2 O at RT for 10 min and 0.1 M Tris/0.05 M EDTA at 42°C for 2 min. Sections were incubated with 20 μg/ml Proteinase K at 37°C for 10 min in a humid chamber. Slides were blocked with 1% BSA/PBS and permeabilized with 0.1% Triton X-in 10 mM sodium citrate (pH6) at 4°C for 2 min. Fifty-microliter reaction mixes were prepared with 31 μl MilliQ H 2 0, 1 mM CoCl2, 60 μM ATP, 0.6 μM FITC-dUTP, 1× TdT buffer, and 125 U of terminal deoxynucleotidyl transferase (TdT) enzyme (Roche Diagnostics Pty Ltd., Australia). A reaction lacking enzyme was performed in parallel as a negative control. Sections were incubated for 1 h at 37°C in a dark Fig. 1 . RT-PCR screen for SDF1-α, -β, and -γ transcript expression in neonatal, adult and in vitro cultured ovaries. SDF1-α and -β were detected in ovarian tissue, but not γ. Lung cDNA was used as a positive control for all 3 transcripts. β-actin PCR was performed to confirm integrity of cDNA. Products from reactions with (+) and without (−) reverse transcriptase are shown.
humid chamber, washed with PBS and mounted with SlowFade® Light Antifade reagent (Molecular Probes, USA) prior to viewing.
Results

Detection of SDF-1β and cxcr4 transcripts via microarray analysis
Expression of CXCR4 and SDF1-β was confirmed via screening of CodeLink™ Mouse Whole Genome array slides (GE Healthcare, UK) with 7-day mouse ovary RNA. Normalized intensity values of 4.6 and 0.6 were obtained for the receptor and ligand respectively. Differences in developmental expression were assessed using a 2-color comparison between 2-day and 7-day neonatal ovary RNA on NIA 15K cDNA microarray slides (AGRF, Australia). SDF1-β (BG086320) was up-regulated 3.90-fold (±SE 0.46) and CXCR4 (BG063365) up-regulated 2-fold (±SE 0.37). Other SDF1 transcript variants were not present on either microarray. Real-time PCR analysis confirmed the up-regulation of the ligand gene expression with 1.81 (±SE 0.20)-fold difference. CXCR4 expression was also consistently up-regulated with a mean 1.49 (±SE 0.40)-fold increase in expression. The high variation detected between array and real-time PCR replicates is likely to reflect the differences in numbers of activated versus non-activated follicles per experiment.
RT-PCR analysis of SDF1 and CXCR4-transcript variants present in mouse ovary
Detection of SDF1-β in the microarray analysis prompted the search for other SDF1 transcript variants not present in the NIA cDNA clone set. RT-PCR confirmed the presence of SDF1 transcript variants 1 and 2 (SDF-α and -β) in cultured, neonatal and adult ovary cDNA samples in addition to the lung cDNApositive control. SDF transcript variant 3 (SDF-γ) could not be detected in ovarian tissue but was present in lung tissue (Fig. 1) .
Cellular localization of SDF1 and CXCR4 receptor mRNA and protein in ovarian tissue
Both receptor and ligand messages displayed highly similar expression patterns in neonatal ovarian tissue. Messenger RNA was detected prominently in the oocytes of primordial and primary/secondary oocytes, with lower levels of staining in the interstitial tissue and granulosa cells (Fig. 2) . CXCR4 protein was detected in the oocytes and granulosa cells of primordial and activated follicles (Fig. 3A) . SDF1 immunostaining revealed a highly similar protein expression pattern, with intensity of staining increasing with follicle size (Fig. 3B) . Dual immunostaining assessed using multi-tracking confocal scanning microscopy confirmed oocyte expression of both ligand and receptor (Figs. 3C-E) . To determine when this autocrine pattern of expression of ligand and receptor is established in the murine gonad, mRNA expression in both the female and male gonad was analyzed by microarray and real-time PCR analysis on embryonic gonads. Affymetrix microarray screening of 11.5 dpc, 12.5 dpc, and 13.5 dpc embryos revealed high levels of expression of SDF-α and -β over the time period in both gonads, with negligible levels of SDF1-γ (Table 1) . For further evaluation of trends in Table 1 Results of Affymetrix microarray analysis of SDF1 transcript variants in the 11.5, 12.5, and 13.5 dpc male and female mouse embryonic gonad Female Male 11.5 dpc 12.5 dpc 13.5 dpc 11.5 dpc 12.5 dpc 13.5 dpc Affymetrix signal values plus and minus the standard error of the mean are given. Negligible SDF1-γ levels were detected in either sex for any of the time points examined. Similar levels of SDF1-α and -β were detected in the male and female at the first time point of 11 dpc. A trend of decreasing levels of SDF1-α and β was observed over the time period 11.5 to 13.5 for the female. A decrease in SDF1-α and -β levels in the male was followed by an increase and observed over the same time period for the male.
transcript expression, real-time PCR was performed over the same time period as well as days 15.5 dpc and 17.5 dpc. Primers were designed for dual detection of SDF1-α and SDF1-β transcripts considering their congruous pattern of expression in the Affymetrix microarray data. Real-time PCR analysis revealed a highly dichotomous SDF1 expression pattern between the male and female gonad. Low to negligible levels of transcripts were present after 11.5 dpc in the female gonad, with a significant increase in expression from 11.5 dpc to 15.5 dpc in the male gonad followed by a decrease by 17.5 dpc (Fig. 4) . Immunohistochemistry confirmed protein expression of both ligand and receptor in the differentiated male gonad (Fig. 5) . The consistent staining pattern indicated expression in both the germ and somatic cells of the male tubule with little interstitial cell staining. Low levels of staining suggested CXCR4 and SDF1 proteins were also present in the female differentiated gonad in both germ cells and somatic cells. The lack of transcript at these time points indicates this may represent remnant protein from the time period corresponding to completion of primordial germ cell migration and colonization of the indifferent gonad (∼11.dpc).
Effect of recombinant SDF1-α and CXCR4 inhibitor AMD3100 on cultured neonatal ovaries
The ovarian culture media used for this study allowed for significant, but not exhaustive, levels of follicle activation in neonatal Swiss outbred mouse ovaries. Factors were included that have previously been shown to enhance follicle activation such as LIF, bFGF, and SCF (Nilsson et al., 2001 (Nilsson et al., , 2002 Parrott and Skinner, 1999) . These were considered necessary for optimal ovary health while still allowing a mixture of primordial and primary follicles to survive, therefore allowing for an analysis of either an enhancement or repression of follicle activation.
Incubation with recombinant SDF1-α resulted in a dosedependent increase in follicle densities for additions in the range of 10 to 250 ng/ml of SDF1-α (Fig. 6A) . In contrast, treatment of ovaries with a CXCR4 specific antagonist of SDF1 binding, AMD3100, in the presence of 250 ng/ml of SDF1-α reduced follicles densities back to control levels (Fig. 6B) .
In order to determine whether the increase in follicle densities was a result of a decrease in follicular apoptosis in response to SDF1-α, TUNEL assays were performed on cultured ovarian sections. Similar levels of apoptotic cell staining for control and ovaries treated with 250 ng/ml SDF1-α were observed (Fig. 7) . The low-level, sporadic TUNEL labeling was not indicative of necrotic tissue thereby confirming the healthy status of the cultured ovaries. Staining occurred primarily in somatic cells as determined by morphological assessment.
To test the alternative hypothesis that the higher follicle densities seen in treated ovaries were a result of a block in follicle activation, measurements of oocyte follicle diameters of control and 250 ng/ml SDF1-α treated explants were assessed. Oocyte growth is an established marker of follicle activation together with the transition of granulosa cells from squamous to cuboidal morphology and subsequent proliferation (Lintern- Moore and Moore, 1979) . A difference in the distribution pattern of oocyte diameters was indeed obtained, with control ovaries displaying a shift toward larger oocyte sizes in comparison with ovaries treated with 250 ng/ml SDF1-α (Fig. 8A) . A statistically significant difference (P < 0.05) was obtained for numbers of oocytes greater than or equal to 24 μm in diameter between control and 250 ng/ml SDF1-α treated (Fig. 8B) .
Discussion
The detection of a chemokine receptor and ligand in the neonatal ovary was an intriguing discovery as chemokines have received little attention as candidates for regulators of early female germ cell development. Rather, the focus has been on Fig. 4 . Real-time PCR analysis of SDF1-α/β transcript in embryonic mouse gonads. From 12.5 to 17.5 dpc, a dichotomous expression pattern exists between the male and female gonad. A statistically significant increase in the levels of SDF1-α/β expression was observed over time for the male (up to day 15.5 dpc), which decreased by day 17.5. After initially similar levels of SDF1-α/β at day 11.5 dpc, levels in the female decreased and remained low to undetectable by day 17.5 dpc (P < 0.02). Following detection of the SDF1-β transcript in the neonatal ovary, we sought to establish whether other SDF1 transcripts were also present, in particular SDF1-α which is the isoform most widely reported upon in the literature. Abundant expression of SDF1-α and -β transcripts has been reported in the adult human ovary (Shirozu et al., 1995) . Both SDF1-α and SDF1-β but not SDF1-γ were detected in neonatal, cultured, and adult mouse ovarian tissue (Fig. 1) . The lack of SDF1-γ in mouse ovarian tissue was not unexpected given that SDF1-β and -γ have previously been shown to be inversely expressed in somatic tissues of the adult rat (Gleichmann et al., 2000) . The authors reported a lack of SDF1-α and differential expression of SDF1-β and -γ in the brain during rat embryogenesis, suggesting that expression of various SDF1 transcripts and protein has important functional relevance. As SDF1-α is the best characterized SDF transcript variant in the literature, it was selected as the isoform for localization and functional studies. That SDF1-β is playing a distinct role in the developing ovary cannot, however, be discounted. For example, migrating primordial germ cells in the chick embryo can be directed by SDF1-α but not SDF1-β (Stebler et al., 2004) .
Both SDF1-α and CXCR4 mRNA and protein localized to the primordial and primary follicles. The uniformity of gene expression across different stage follicles by in situ hybridization indicated SDF1 and CXCR4 transcripts may not necessarily be up-regulated upon follicle activation. The apparent up-regulation may be due to the greater proportion of oocyte cytoplasmic volume in the 7-day ovary compared with the 2-day ovary, due the rapid enlargement of the oocyte once activated. The detection of both transcripts in the primordial follicle oocyte was nonetheless interesting as the primordial oocyte is essentially a "resting" cell with relatively limited metabolic capability (Moore et al., 1974; Oakberg, 1968) , suggesting that the chemokine and receptor may be performing an essential role within the follicle. A dose-dependent increase in follicle density was observed following treatment with SDF1-α up to 250 ng/ml. (B) Treatment of cultured ovaries with CXCR4 antagonist AMD3100 (100 μM) in combination with SDF1-α (250 ng/ml) resulted in significantly lower follicle densities than ovaries treated with SDF1-α alone. Treatment with AMD3100 in combination with SDF1-α gave follicle densities similar to those of control ovaries or those treated with AMD3100 alone. Significance (P < 0.02) between groups is represented by different letters.
The role of SDF1 in primordial germ cell migration relies on the expression of the ligand by the dorsal body wall, particularly in the mesonephros and adjacent mesenchyme tissue, which aids in directing the primordial germ cells to the embryonic gonad (Molyneaux et al., 2003; Stebler et al., 2004) . In order to gain insight into when dual expression of ligand and receptor in the gonad first occurs, we analyzed SDF1 expression in the male and female embryonic gonad, pre-and post-differentiation. SDF1-α/β transcripts were detected via Affymetrix array screening in both sexes over a broad time period corresponding to the latter migratory period (11.5 dpc), gonad colonization/beginning of differentiation (12.5 dpc), female meiotic I entry (13.5 dpc), and postdifferentiation (17.5 dpc). In agreement with the post-natal ovary SDF1 transcript profile, SDF-γ expression was negligible. Real-time PCR confirmed SDF1 expression at similar levels in the 11.5 dpc indifferent gonad of both sexes. In agreement with this, Stebler et al. (2004) reported the presence of SDF-α and -β in the genital ridges of embryos of this stage, where its expression is likely to be required for the attraction of the primordial germ cells to the indifferent gonad (11.5 dpc). We report for the first time the SDF1 pattern of expression in the mouse in the later stages of embryonic gonadal development. Surprisingly, colonization and the beginning of gonadal differentiation (12.5 dpc onwards) marked the beginning of a highly dichotomous expression pattern between the sexes, with little to no SDF1 transcript detected in the female gonad past this stage in contrast to the male gonad. These high levels of SDF1 suggest that the ligand may play an important yet unidentified role in the differentiating male gonad distinct from the initial primordial germ cell attractive role which has been established for SDF1. The ligand may be less important in the developing female gonad considering the negligible levels of SDF1 transcript in the female. This is not conclusive however, due to the detection of protein in the differentiating female gonad (13.5 dpc onwards), although this may be residual protein from earlier stages. It is interesting to note that protein was localized in germ cells, which suggests that the ligand begins to be expressed in this cell at some point after migration, between the time of colonization and the start of differentiation, and suggests that the autocrine SDF1/CXCR4 axis in the female germ cell is established well before primordial follicle assembly and activation.
An autocrine pattern of expression for CXCR4 and SDF1 is not unique and has been described in human thyroid carcinoma cell lines (Hwang et al., 2003) and human trophoblasts (Wu et al., 2004b) .The expression profile we have seen overlaps a broad developmental time period in the female germ cell life cycle encompassing the processes the mitotic division, meiotic I entry and meiotic I arrest within the developing gonad. Although a paracrine SDF1/CXCR4 signaling system has been reported to function in germ cell migration, the switch to an autocrine pattern of expression may herald a concomitant change in function. Our study did not address function in the embryonic gonad; however an anti-apoptotic or pro-angiogenic role could be envisaged. Activation of SDF1/CXCR4 signaling pathways influences a plethora of cellular processes including chemotaxis, secretion, adhesion, cell survival, through activation of PLC, PI3 kinase, and MAPK/ERKs and varies greatly with cell type (Kucia et al., 2004; Murdoch, 2000; Scotton et al., 2002) .
Our study sought to instead establish a functional role for CXCR4/SDF upon the newly formed primordial follicle pool which represents the limited source from which mature female gametes may arise. Once primordial follicles activate, they are destined to enter the growing follicle pool, or undergo atresia. Greater than 99% of all follicles that enter the growing pool die, thus making the maintenance of the primordial follicle pool a crucial determinant of the reproductive lifespan of the Fig. 7 . Effect of 250 ng/ml SDF1-α on levels of apoptosis in the neonatal 5-day cultured ovary. TUNEL analysis indicated no observable differences in cellular apoptosis between SDF1-α treated ovaries (A) and PBS-treated control ovaries (B). A reaction lacking Tdt enzyme was included as a negative control (C). Scale bar = 40 μm. mammalian female (Faddy et al., 1983; Gosden et al., 1983; Tilly, 2001) .
Treatment of neonatal ovaries in culture resulted in greater follicle densities, and follicles of smaller size following SDF1-α exposure, suggesting the chemokine is acting as an inhibitor of follicle activation. Moreover, this effect is specifically mediated by signaling through CXCR4, since the CXCR4 specific antagonist AMD3100 abrogates this effect. The lower follicle density and larger follicles seen in untreated control ovaries suggests that more follicles are able to activate in the absence of high levels of SDF1-α and enter the follicle development cycle, although they cannot survive beyond the secondary stage in the whole organ culture system used in this study.
The only other reported inhibitor of primordial follicle activation is the TGFβ superfamily-member, anti-Müllerian hormone (AMH). In contrast to SDF1, AMH acts in a paracrine manner, with protein expressed by the granulosa cells of activated follicles only (Durlinger et al., 2002b) . Similarly to AMH, our findings indicate that primordial follicle activation is not completely attenuated by either SDF1-α alone, highlighting the fact that the activation process is influenced by a balance of both stimulatory and inhibitory factors.
In conclusion, the results of this study demonstrate the autocrine expression of the chemokine SDF1-α and its receptor CXCR4 in the female gamete, during early developmental and perinatal period of the mouse female germ cell development and indicate that the signaling axis may play an important role inhibiting follicle activation. Further studies will elucidate the signaling pathways involved in this process and the interactions with other key factors implicated in the primordial to primary follicle transition. Additionally, an important role for SDF1/CXCR4 in the developing male gonad distinct from a migratory role is predicted and is currently being explored. There was a statistically significant difference in numbers of oocytes 24 μm and above, between control and SDF1-α treated ovaries (P < 0.05).
